Skip to content

Company information lookup

PROGEN PHARMACEUTICALS LIMITED (PGL)

Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PGL 0.880 -2.22% 0.900 0.985 0.880 0.880 0.880 3,740

PROGEN PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PGL
Securities
Official Listing Date 22 December, 1995
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.progen-pharma.com
Registered Office Address 2806 Ipswich Rd, DARRA, QLD, AUSTRALIA, 4076
Head Office Telephone (07) 3273 9133
Head Office Fax (07) 3375 1168
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
117 VICTORIA STREET, WEST END, QLD, AUSTRALIA, 4101
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Jitto Arulampalam (Non Exec. Chairman)
Mr Heng Tang (Managing Director)
Mr Hongjen Chang (Non Exec. Director)
Company Secretary Mr Blair Lucas
Principal Activities Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

PROGEN PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
09/04/2014 asterix PG545 Data Presented at AACR Conference 2 PDF
02/04/2014   Issue of Unlisted Options under ESOP 13 PDF
17/03/2014 asterix Response to ASX Price Query 4 PDF
13/03/2014   Change of Director's Interest Notice 2 PDF
27/02/2014 asterix Half Yearly Report and Accounts 20 PDF
13/02/2014   PG545 Data Presented at Lorne Cancer Conference 2 PDF
31/01/2014   Receipt of R& D Tax Incentive Refund 1 PDF
30/01/2014 asterix Response to ASX Price Query 3 PDF
30/12/2013 asterix PATRON Trial Completes Patient Recruitment 2 PDF
20/12/2013   Change of Director's Interest Notice 4 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Apr 2014 0.880 -2.22% 0.880 0.880 3,740
23 Apr 2014 0.900 -5.26% 0.900 0.870 21,000
22 Apr 2014 0.950 7.95% 0.960 0.900 22,223
17 Apr 2014 0.880 -6.38% 0.880 0.870 39,667
11 Apr 2014 0.940 0% 0.940 0.890 102,078

* Volume of shares shown represents only those shares traded on ASX.

PROGEN PHARMACEUTICALS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PGL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PGL

Warrants & Structured Products

No warrants & Structured Products are available over the security PGL

ASX CFDs

No Contracts For Differences are available over the security PGL